Results 101 to 110 of about 5,892 (166)

Comment on Yamazaki et al. Long-Term Effects of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Predictors of Treatment Response and Safety over 6 Years of Continuous Therapy. <i>Int. J. Mol. Sci.</i> 2024, <i>25</i>, 2088. [PDF]

Int J Mol Sci
De Rosa LI, Catania M, Kola K, Vezzoli G, Brambilla Pisoni M, Farinone S, Manunta P, Sciarrone Alibrandi MT.   +7 more
europepmc   +1 more source

Vaptans: A Narrative Review of Pharmacokinetics, Pharmacogenetics, and Clinical Applications. [PDF]

Cells
Lica-Miler M, Miler K, Kostrzewa-Nowak D, Ciechanowicz A, Brodkiewicz A, Różański J, Stępniewska J.   +6 more
europepmc   +1 more source

Diuretic therapy for critically ill patients: a systematic review and network meta-analysis. [PDF]

Ann Intensive Care
Kuriyama A, Polok K, Malhotra N, Kuse N, Pitre T, Lakhanpal D, Sun R, Soni KD, Campbell K, Burry LD, Clark EG, Lewis K, Møller MH, Gershengorn HB, Rochwerg B.   +14 more
europepmc   +1 more source

Long-term effects of tolvaptan in patients requiring recurrent hospitalization for heart failure

Although reports suggest that tolvaptan does not reduce survival or subsequent hospitalization rates in heart failure patients, its continuous use has shown good outcomes in some patients who cannot be effectively managed with high doses of loop ...
Ishii, Hideki, Osanai, Hiroyuki, Ajioka, Masayoshi, Ogawa, Hayato, Murase, Yosuke, Asano, Hiroshi, Okumura, Takahiro, Nakasima, Yoshihito, Sakai, Kazuyoshi, Murohara, Toyoaki   +9 more
core  

A Rare Case of Preeclampsia-Associated Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) in Twin Pregnancy Treated With Tolvaptan. [PDF]

Cureus
Gilmore N, Colome D, Smith NA, Perrin E, Gomez R.   +4 more
europepmc   +1 more source

GLUT9b- and ABCG2-mediated collecting duct urate transport uncovers a vasopressin-independent mechanism of renal water reabsorption. [PDF]

J Clin Invest
Hadla M, Mardirossian JM, Bichet DG, Borghol AH, Abboud G, Ghanem A, Chini E, Harris P, Torres VE, Alper SL, Vallon V, Chebib FT.   +11 more
europepmc   +1 more source

Development of Orally Disintegrating Tablets from Solid Dispersions Containing Tolvaptan/Cyclodextrin Complexes [PDF]

Turk J Pharm Sci
Kara AA, Tort S, Acartürk F.
europepmc   +1 more source

Adding Tolvaptan in the Inpatient Treatment for Patients with Heart Failure and Hyponatremia: Budget Impact Analysis in Thailand

ClinicoEconomics and Outcomes Research
Unchalee Permsuwan,1,2 Krit Leemasawat,3 Poukwan Arunmanakul1,2,4 1Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand; 2Center for Medical and Health Technology Assessment (CM-HTA), Department of ...
Permsuwan U, Leemasawat K, Arunmanakul P
doaj  

Baseline hematuria in autosomal dominant polycystic kidney disease. [PDF]

Clin Kidney J
Serra A, Serra JH, Severin M, Russmann S.   +3 more
europepmc   +1 more source

Successful treatment of chronic alcohol-induced refractory hyponatremia with tolvaptan: a case report with in-depth analysis of traditional treatment failure mechanisms. [PDF]

Front Pharmacol
Yan K, Zhou J, Zeng H, Liu D, Tao W, Fang Z, Yang X.   +6 more
europepmc   +1 more source